Illustrative image – not actual.Ipca Laboratories has planned to invest Rs.100 crore in expanding the formulation capacity of its existing units. Another Rs.50 crore would be invested in setting up a greenfield unit. The company is also mulling expansion through the acquisition route for which it is scouting for units in Europe.
Although a major part of the capital investment would be financed through internal accruals, the company is also considering raising $15 million through external commercial borrowings.
The brownfield expansion of Rs.100 crore would be mainly done at the formulation unit at Silvassa. The location for the greenfield unit is being decided.
Ipca has a bulk drugs and formulation unit at Ratlam and a bulk drug facility at Indore, both in Madhya Pradesh. It has two formulation units at Kandla in Gujarat.
